Position in ICLR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$192,132,987
+$69,872,389 QoQ
Shares Held
1,106,056
+0.1% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 422 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capital World Investors holds $6,483,252,498 across 6 Diagnostics & Research names. ICLR ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,195,370 | $3,106,110,703 | |
| 2 | ILMN |
Illumina, Inc.
|
15,425,298 | $2,712,230,147 | |
| 3 | NTRA |
Natera, Inc.
|
1,504,387 | $408,365,851 | |
| 4 | ICLR |
Icon PLC
This page
|
1,106,056 | $192,132,987 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
316,887 | $61,228,906 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
14,039 | $3,183,904 |
All Filings in ICLR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $192,132,987 | 1,106,056 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $122,260,598 | 1,104,831 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $272,688,403 | 1,496,479 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $39,967,200 | 228,384 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $380,398 | 1,324 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||